In 2023, Regeneron Pharmaceuticals disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.
Regeneron Pharmaceuticals disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.
Finally, Regeneron Pharmaceuticals also reported the types of energy sources as well as generation technologies, helping stakeholders evaluate Regeneron Pharmaceuticals's reliance on fossil fuels versus cleaner alternatives.
Metric (GJ) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Renewable Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-renewable Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Electricity Consumed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected energy data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, Regeneron Pharmaceuticals consumed a total of 740,880 Gigajoules of energy across its operations. Of this total, 22% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 78% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.
In 2023, Regeneron Pharmaceuticals consumed a total of 740,880 Gigajoules of energy, of which 22% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.
This low level of renewable energy use highlights a heavy reliance on fossil fuels or other non-renewable sources, suggesting that Regeneron Pharmaceuticals has considerable room to improve its energy sustainability strategy.
Since 2020, Regeneron Pharmaceuticals's total energy consumption increased by 25.49%, including a 6.52% increase in 2023, reflecting a sustained rise in overall energy demand.
Over the same period, the share of renewable energy in Regeneron Pharmaceuticals's consumption increased by 10%, including a 10% increase in 2023, showing consistent progress in clean energy adoption.
Overall, Regeneron Pharmaceuticals has seen rising energy demand, but has also made strong and consistent progress in increasing its reliance on renewable energy—mitigating the environmental impact of its growing consumption.
In 2023, Regeneron Pharmaceuticals disclosed detailed information on the sources and generation technologies of the energy it consumed. This disclosure enables a clearer assessment of the Regeneron Pharmaceuticals's overall energy mix, its sourcing strategy, and its reliance on fossil fuels versus cleaner alternatives such as renewables and low-carbon technologies.
In 2023, Regeneron Pharmaceuticals's total energy consumption was primarily sourced from
In 2023, Regeneron Pharmaceuticals consumed energy from 2 different sources or generation technologies, indicating a highly concentrated energy mix, with Solar Energy and Electricity (Unspecified Source) alone accounting for 81.97% of total consumption.